BrandowA. M., CarrollC. P., CrearyS., Edwards-ElliottR., GlassbergJ., HurleyR. W., KutlarA., SeisaM., StinsonJ., StrouseJ. J., YusufF., ZempskyW., & LangE. (2020). American Society of Hematology 2020 guidelines for sickle cell disease: Management of acute and chronic pain. Blood Advances, 4(12), 2656–2701. https://doi.org/10.1182/bloodadvances.2020001851
2.
PaiceJ. A., BohlkeK., BartonD., CraigD. S., El-JawahriA., HershmanD. L., KongL. R., KuritaG. P., LeBlancT. W., MercadanteS., NovickK. L. M., SedhomR., SeigelC., StimmelJ., & BrueraE. (2023). Use of opioids for adults with pain from cancer or cancer treatment: ASCO Guideline. Journal of Clinical Oncology, 41(4), 914–930. https://doi.org/10.1200/jco.22.02198
3.
PaiceJ. A., PortenoyR., LacchettiC., CampbellT., ChevilleA., CitronM., ConstineL. S., CooperA., GlareP., KeefeF., KoyyalaguntaL., LevyM., MiaskowskiC., Otis-GreenS., SloanP., & BrueraE. (2016). Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. Journal of Clinical Oncology, 34(27), 3325–3345. https://doi.org/10.1200/JCO.2016.68.5206
4.
RikardS. M., StrahanA. E., SchmitK. M., & GuyG. P.Jr. (2023). Chronic pain among adults—United States, 2019–2021. Morbidity and Mortality Weekly Report, 72(15), 379–385. https://doi.org/10.15585/mmwr.mm7215a1
5.
SchneiderhanJ., ClauwD. J., & SchwenkT. L. (2017). Primary care of patients with chronic pain. JAMA, 317(23), 2367–2368. https://doi.org/10.1001/jama.2017.5787
6.
MorascoB. J., GritznerS., LewisL., OldhamR., TurkD. C., & DobschaS. K. (2011). Systemic review of prevalence, correlates, and treatment outcomes for chronic non-cancer pain in patients with comorbid substance use disorder. Pain, 152(3), 488–497.
7.
HootenW. M. (2016). Chronic pain and mental health disorders: Shared neural mechanisms, epidemiology, and treatment. Mayo Clinic Proceedings, 91(7), 955–970. https://doi.org/10.1016/j.mayocp.2016.04.029
8.
ÅkerblomS., PerrinS., Rivano FischerM., & McCrackenL. M. (2018). The relationship between posttraumatic stress disorder and chronic pain in people seeking treatment for chronic pain: The mediating role of psychological flexibility. The Clinical Journal of Pain, 34(6), 487–496. https://doi.org/10.1097/AJP.0000000000000561
9.
SmithM. T., EdwardsR. R., RobinsonR. C., & DworkinR. H. (2004). Suicidal ideation, plans, and attempts in chronic pain patients: Factors associated with increased risk. Pain, 111(1), 201–208. https://doi.org/10.1016/j.pain.2004.06.016
10.
AgnoliA., XingG., TancrediD. J., MagnanE., JerantA., & FentonJ. J. (2021). Association of dose tapering with overdose or mental health crisis among patients prescribed long-term opioids. JAMA, 326(5), 411–419. https://doi.org/10.1001/jama.2021.11013
11.
RacineM. (2018). Chronic pain and suicide risk: A comprehensive review. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 87(B), 269–280. https://doi.org/10.1016/j.pnpbp.2017.08.020
12.
LyD. P. (2019). Racial and ethnic disparities in the evaluation and management of pain in the outpatient setting, 2006–2015. Pain Medicine, 20(2), 223–232. https://doi.org/10.1093/pm/pny074
13.
HoffmanK. M., TrawalterS., AxtJ. R., & OliverM. N. (2016). Racial bias in pain assessment and treatment recommendations, and false beliefs about biological differences between blacks and whites. Proceedings of the National Academy of Sciences, 113(16), 4296–4301. https://doi.org/10.1073/pnas.1516047113
DowellD., RaganK. R., JonesC. M., BaldwinG. T., & ChouR. (2022). CDC clinical practice guideline for prescribing opioids for pain—United States, 2022. Morbidity and Mortality Weekly Report, 71(3), 1–95. https://doi.org/10.15585/mmwr.rr7103a1
18.
SandbrinkF., MurphyJ. L., JohanssonM., OlsonJ. L., EdensE., Clinton-LontJ., SallJ., & SpevakC. (2023). The use of opioids in the management of chronic pain: Synopsis of the 2022 updated U.S. Department of Veterans Affairs and U.S. Department of Defense clinical practice guideline. Annals of Internal Medicine, 176(3), 388–397. https://doi.org/10.7326/m22-2917
19.
BallyM., DendukuriN., RichB., NadeauL., Helin-SalmivaaraA., GarbeE., & BrophyJ. M. (2017). Risk of acute myocardial infarction with NSAIDs in real world use: Bayesian meta-analysis of individual patient data. BMJ, 357, j1909. https://doi.org/10.1136/bmj.j1909
20.
GoodmanC. W., & BrettA. S. (2017). Gabapentin and pregabalin for pain—Is increased prescribing a cause for concern?. New England Journal of Medicine, 377(5), 411–414. https://doi.org/10.1056/nejmp1704633
SkellyA. C., ChouR., DettoriJ. R., TurnerJ. A., FriedlyJ. L., RundellS. D., FuR., BrodtE. D., WassonN., KantnerS., & FergusonA. J. R. (2020). Noninvasive nonpharmacological treatment for chronic pain: A systematic review update (AHRQ Publication No. 20-EHC009). Agency for Healthcare Research and Quality. https://doi.org/10.23970/ahrqepccer227
23.
QaseemA., WiltT. J., McLeanR. M., & ForcieaM. A. (2017). Noninvasive treatments for acute, subacute, and chronic low back pain: A clinical practice guideline from the American College of Physicians. Annals of Internal Medicine, 166(7), 514–530. https://doi.org/10.7326/M16-2367
24.
PollackS. W., SkillmanS. M., & FrognerB. K. (2020). The health workforce delivering evidence-based non-pharmacological pain management. University of Washington Center for Health Workforce Studies.